3.94 (-%)
As of Oct 30, 2024
Source:
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases. Our current focus areas include Hepatitis B virus, SARS-CoV-2, and other coronaviruses.
| Country | United States |
| Headquarters | warminster, pennsylvania |
| Phone Number | 604-419-3200 |
| Industry | manufacturing |
| CEO | William H. Collier |
| Website | www.arbutusbio.com |